Zobrazeno 1 - 10
of 176
pro vyhledávání: '"A. K. Mantel-Teeuwisse"'
Publikováno v:
BMC Research Notes, Vol 17, Iss 1, Pp 1-7 (2024)
Abstract Objective Despite global recognition that access to medicines is shaped by various interacting processes within a health system, a suitable analytical framework for identifying barriers and facilitators from a system’s perspective was need
Externí odkaz:
https://doaj.org/article/13478b272c0a447e8c78789351402ee7
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 17, Iss 1 (2024)
ABSTRACTBackground This study explored the treatment-related, financial and psychological experiences of caregivers during cancer treatment of their children in South Africa’s (SA) public and private sectors.Methods In this exploratory study, three
Externí odkaz:
https://doaj.org/article/76b4c41215f74f1490a0d2989df75782
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 17, Iss 1 (2024)
Background: The WHO Essential Medicine List for Children was released on the 30th anniversary of the general Essential Medicine List in 2007, to recognise special needs for medicines in children, and to promote the inclusion of paediatric medicines i
Externí odkaz:
https://doaj.org/article/a43843e6a2d84f35a6a7775d182056b7
Publikováno v:
BMC Health Services Research, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Introduction The COVID-19 pandemic highlighted an urgent need for harmonised requirements for the regulation of medicines. To fully implement harmonised medicines regulations across Africa, common technical standards of medicine regulations
Externí odkaz:
https://doaj.org/article/35574983a7684074aa0f4468670a0e65
Autor:
I. R. Joosse, V. J. Wirtz, A. T. van Mourik, B. A. Wagner, A. K. Mantel-Teeuwisse, F. Suleman, H. A. van den Ham
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Sustainable Development Goal (SDG) indicator 3.b.3 monitors progress in medicines’ accessibility for adults and has significant limitations when applying to medicines for children. An adapted indicator methodology was developed
Externí odkaz:
https://doaj.org/article/c1db9a6e7ba740e29baff81e6a8b6c2e
Autor:
M. Dankers, M. J. E. van den Berk-Bulsink, M. van Dalfsen-Slingerland, H.J.M.G. Nelissen-Vrancken, A. K. Mantel-Teeuwisse, L. van Dijk
Publikováno v:
BMC Primary Care, Vol 23, Iss 1, Pp 1-10 (2022)
Abstract Background Guideline adherence is generally high in Dutch general practices. However, the prescription of insulins to type 2 diabetes mellitus patients is often not in line with the guideline, which recommends NPH insulin as first choice and
Externí odkaz:
https://doaj.org/article/41e5ddbadcc0430c8fc117d213b5d65a
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 14, Iss 1 (2021)
Background Sub-Saharan Africa is going through an epidemiological transition, including an impressive increase in non-communicable diseases. The introduction of medicines has not kept pace with the needs in developing countries. The objectives of thi
Externí odkaz:
https://doaj.org/article/61b6452c5ff848daa460c26037f5737c
Publikováno v:
BMC Cardiovascular Disorders, Vol 18, Iss 1, Pp 1-12 (2018)
Abstract Background The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of essential medicines for the prev
Externí odkaz:
https://doaj.org/article/1b8657c988354b40826bed8f7efb1f26
Autor:
J. M. van den Heuvel, A. M. Hövels, H. R. Büller, A. K. Mantel-Teeuwisse, A. de Boer, A. H. Maitland-van der Zee
Publikováno v:
Thrombosis Journal, Vol 16, Iss 1, Pp 1-10 (2018)
Abstract Background In 2012, around 400.000 patients in the Netherlands were treated with Vitamin K Antagonists (VKA) for thromboembolic diseases. Since 2011, non-VKA oral anticoagulants (NOACs) are available. NOACs do not require frequent INR monito
Externí odkaz:
https://doaj.org/article/27958c4f5cb74c558309e1cd43ca9ab5
Publikováno v:
BMC Health Services Research, Vol 17, Iss 1, Pp 1-9 (2017)
Abstract Background In the last 20–30 years, many international studies have found substantial differences in the use of (older) psychotropic medication between European countries. The majority mentioned an important role for attitudes and beliefs
Externí odkaz:
https://doaj.org/article/0f6f741b97a4403c80a05746b4a30a4d